載入...
PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study
Although immune checkpoints inhibitors have exhibited promising activity in clinical trials in non-small cell lung cancer (NSCLC) patients, the current programmed cell death-ligand 1 (PD-L1) assays are inconsistent in terms of the staining analysis and scoring system used. To verify the interchangea...
Na minha lista:
| 發表在: | Oncotarget |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Impact Journals LLC
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5716747/ https://ncbi.nlm.nih.gov/pubmed/29228707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21567 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|